Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations
Keita Masuzawa(Keio University), Tomoko Betsuyaku(Keio University)
Cited by 55
Related Papers
Prognostic values of the Berlin definition criteria, blood lactate level, and fibroproliferative changes on high-resolution computed tomography in ARDS patients
|BMC Pulmonary Medicine|2019|55
Modulation of Murine Macrophage TLR7/8-Mediated Cytokine Expression by Mesenchymal Stem Cell-Conditioned Medium
|Mediators of Inflammation|2013|53
Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer
|Lung Cancer|2013|49